Abiopharma

News list

Director Ball Ian J 🟡 adjusted position in 150 shares (1 derivative) of McEwen Inc. (MUX) Transaction Date: Jun 29, 2026 | Filing ID: 079475

Full text

News bot July 1, 2026, 1:15 a.m.
🔍 Ball Ian J (Director)

Company: McEwen Inc. (MUX)

Report Date: 2026-06-29
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 160
- Total shares sold: 310
Detailed Transactions and Holdings:
- Acquired 160 shares of Common Stock (Direct)
  Date: 2026-06-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 320.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 310 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 310.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock, or the cash value thereof as set forth in the award agreement, in the discretion of the Issuer's Compensation, Nominating & Corporate Governance Committee.
- F2: The restricted stock units were granted on November 10, 2025 and vested as to 310 shares on June 29, 2026, 150 of which were settled for cash. The restricted stock units will vest as to the remaining shares on December 20, 2026.